loading page

Cancer is not a risk factor for severe COVID-19 in children, except in patients with recent allogeneic hematopoietic stem cell transplantion recipients or comorbidities.
  • +31
  • Pablo Velasco Puyó,
  • Alfredo Tagarro,
  • Susana Garcia-Obregon,
  • Olatz Villate Bejarano,
  • Cinta Moraleda,
  • Jorge Huerta Aragonés,
  • Eduardo Bardón-Cancho,
  • Anna Faura Morros,
  • Víctor Galán-Gómez,
  • Laura Escobar Fernández,
  • Francisco Lendinez-Molinos,
  • Blanca Herrero,
  • Laura Ureña Horno,
  • Nerea Domínguez-Pinilla,
  • Juan Francisco Pascual Gazquez,
  • Cristina Nova Lozano,
  • Marta Osuna-Marco,
  • Inés Marín-Cruz,
  • Irene Gomez Pastrana,
  • Nagore Garcia de Andoin,
  • Nerea Gallego Mingo,
  • Raquel Portugal Rodríguez,
  • Adela Cañete,
  • Marta Pareja León,
  • Sara Castrillo Bustamante,
  • María Tallón García,
  • Almudena Gónzalez-Prieto,
  • María Solé-Rodríguez,
  • Macarena González Cruz,
  • Antonio Soriano Arandes,
  • Miriam Mota,
  • Santiago Pérez-Hoyos,
  • Lucas Moreno,
  • Itziar Astigarraga-Aguirre
Pablo Velasco Puyó
Hospital Universitari Vall d'Hebron

Corresponding Author:[email protected]

Author Profile
Alfredo Tagarro
Instituto de Investigacion Hospital 12 de Octubre
Author Profile
Susana Garcia-Obregon
Osakidetza Servicio Vasco de Salud
Author Profile
Olatz Villate Bejarano
Hospital Universitario 12 de Octubre
Author Profile
Cinta Moraleda
Instituto de Investigacion Hospital 12 de Octubre
Author Profile
Jorge Huerta Aragonés
Hospital Materno Infantil Gregorio Maranon
Author Profile
Eduardo Bardón-Cancho
Hospital Materno Infantil Gregorio Maranon
Author Profile
Anna Faura Morros
Hospital Sant Joan de Deu
Author Profile
Víctor Galán-Gómez
Hospital Universitario La Paz Hospital Infantil
Author Profile
Laura Escobar Fernández
Hospital Clinico Universitario de Valladolid
Author Profile
Francisco Lendinez-Molinos
Hospital Infanta Leonor
Author Profile
Blanca Herrero
Hospital Infantil Universitario Nino Jesus
Author Profile
Laura Ureña Horno
Alicante Hospital General
Author Profile
Nerea Domínguez-Pinilla
Instituto de Investigacion Hospital 12 de Octubre
Author Profile
Juan Francisco Pascual Gazquez
Hospital Universitario Virgen de las Nieves
Author Profile
Cristina Nova Lozano
Fundacion Investigacion Clinico de Valencia
Author Profile
Marta Osuna-Marco
HM Hospitales
Author Profile
Inés Marín-Cruz
Hospital Universitario Virgen del Rocio Unidad de Pediatria
Author Profile
Irene Gomez Pastrana
Hospital Universitario 12 de Octubre
Author Profile
Nagore Garcia de Andoin
Osakidetza Servicio Vasco de Salud
Author Profile
Nerea Gallego Mingo
Hospital Universitario Son Espases
Author Profile
Raquel Portugal Rodríguez
Hospital Universitario de Burgos
Author Profile
Adela Cañete
Hospital Universitari i Politecnic La Fe
Author Profile
Marta Pareja León
Complejo Hospitalario Universitario de Albacete
Author Profile
Sara Castrillo Bustamante
Complejo Asistencial de Segovia
Author Profile
María Tallón García
Hospital Alvaro Cunqueiro
Author Profile
Almudena Gónzalez-Prieto
Hospital Universitario de Salamanca
Author Profile
María Solé-Rodríguez
Hospital Universitario Juan Ramon Jimenez
Author Profile
Macarena González Cruz
Hospital Universitario de Canarias
Author Profile
Antonio Soriano Arandes
Hospital Universitari Vall d'Hebron
Author Profile
Miriam Mota
Vall d'Hebron Institut de Recerca
Author Profile
Santiago Pérez-Hoyos
Vall d'Hebron Institut de Recerca
Author Profile
Lucas Moreno
Hospital Universitari Vall d'Hebron
Author Profile
Itziar Astigarraga-Aguirre
Osakidetza Servicio Vasco de Salud
Author Profile

Abstract

The EPICO-SEHOP platform gathers data from children with SARS-CoV-2 in Spain, allowing comparison between children with cancer or allogeneic hematopoietic stem cell transplantation (alloHSCT) and those without. The infection is milder in the cancer/alloHSCT group than in children without comorbidities (7.1% vs. 15%), except in children with recent alloHSCT (less than 300 days), of which 35.7% experienced severe COVID-19. These data have been shared with the SEHOP members to support treatment and isolation policies akin to those for children without cancer, except for those with recent alloHSCT or additional comorbidities. This highlights the collaborative registries potential in managing pandemic emergencies.
24 Jan 2024Submitted to Pediatric Blood & Cancer
24 Jan 2024Submission Checks Completed
24 Jan 2024Assigned to Editor
24 Jan 2024Review(s) Completed, Editorial Evaluation Pending
24 Jan 2024Reviewer(s) Assigned
13 Feb 2024Editorial Decision: Revise Major
08 May 20241st Revision Received
08 May 2024Submission Checks Completed
08 May 2024Assigned to Editor
09 May 2024Review(s) Completed, Editorial Evaluation Pending
09 May 2024Reviewer(s) Assigned
17 May 2024Editorial Decision: Accept